Marina Rugna

Mrs. Marina Rugna


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LMLivian Cássia De Melo
Livian Cássia De Melo
Marina RugnaMarina Rugna
Marina Rugna
TDTalita Almeida Durães
Talita Almeida Durães
SPStefany Silva Pereira
Stefany Silva Pereira
GCGustavo Yano Callado
Gustavo Yano Callado
Roberta GraneseRoberta Granese
Roberta Granese
Congenital Rubella Syndrome (CRS) results from maternal infection with the rubella virus during pregnancy, particularly in the first trimester, when the risk of vertical transmission and severe fetal damage is highest. CRS is characterized by a broad spectrum of congenital anomalies, including sensorineural hearing loss, congenital heart defects, cataracts, neurodevelopmental delay, and behavioral disorders. Despite the absence of specific antiviral therapies, active immunization remains the only effective strategy to prevent rubella infection and its congenital consequences. Global immunization efforts, particularly in the Americas, have led to the elimination of rubella and CRS in several countries. However, challenges persist in the post-elimination era, including declining vaccine coverage, vaccine hesitancy, and setbacks caused by the COVID-19 pandemic. Diagnosis relies on maternal serology, fetal imaging, postnatal antibody testing, and molecular techniques. Management requires long-term, multidisciplinary follow-up due to the complex and lifelong sequelae affecting sensory, motor, and cognitive development. This review highlights the clinical, epidemiological, and pathophysiological aspects of CRS, while emphasizing the urgent need to maintain high vaccination coverage and strengthen surveillance systems. Sustained public health commitment is essential to prevent the reemergence of rubella and protect future generations from this preventable syndrome.

10 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
LSLuisa Scomparim
Luisa Scomparim
GCGustavo Yano Callado
Gustavo Yano Callado
LMLivian Cássia De Melo
Livian Cássia De Melo
Marina RugnaMarina Rugna
Marina Rugna
SPStefany Silva Pereira
Stefany Silva Pereira
Edward Araujo JúniorEdward Araujo Júnior
Edward Araujo Júnior
Chikungunya virus (CHIKV) infection during pregnancy represents an increasing public health concern, especially in endemic and epidemic regions. The main concern is vertical transmission, particularly during the peripartum period, which can lead to severe neonatal outcomes such as encephalopathy, hematologic abnormalities, and long-term neurodevelopmental impairment. This review synthesizes current knowledge on pathophysiology, clinical manifestations, diagnosis, maternal and neonatal outcomes, and management of CHIKV infection in pregnancy. Diagnosis relies on clinical evaluation supported by laboratory confirmation, RT-PCR in the acute phase and IgM serology thereafter. Treatment is supportive, using acetaminophen as first-line therapy and corticosteroids for selected refractory cases. No antivirals or vaccines are approved for use in pregnancy as of 2025. Prevention is centered on vector control, personal protection, and epidemiological surveillance. Delivery planning and neonatal monitoring are essential when infection occurs close to term due to the high risk of peripartum transmission. Despite growing recognition of CHIKV’s maternal–fetal impact, significant gaps remain regarding long-term outcomes and optimal management strategies. Strengthening prenatal care, neonatal preparedness, and surveillance systems is crucial to mitigate adverse outcomes and inform future clinical and public health policies.

1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
ATAlessandra Costa Timoteo
Alessandra Costa Timoteo
MGMaria Cristina Gabrielloni
Maria Cristina Gabrielloni
RARosemeire Sartori de Albuquerque
Rosemeire Sartori de Albuquerque
Edward Araujo JúniorEdward Araujo Júnior
Edward Araujo Júnior
Marina RugnaMarina Rugna
Marina Rugna
MBMárcia Barbieri
Márcia Barbieri
SUMMARY OBJECTIVE: The aim of this study was to evaluate the participation of obstetric nurses in care provided during labor and delivery within the Brazilian private health system. METHODS: This cross-sectional observational study included women admitted for delivery in six private hospitals—five in São Paulo and one in Santos, Brazil. Data were obtained through structured interviews conducted during the postpartum period and included information on hospital admission, labor and delivery care, healthcare professionals involved, and obstetric interventions. Women with live births during the study period were included. RESULTS: A total of 2,435 postpartum women were interviewed. Among them, 48.2% were in their first pregnancy, and 56.4% were primiparous. Only 14.9% had a previous vaginal delivery, while 31.2% had undergone a previous cesarean section. Labor was attended by a physician in 99.3% of cases. Although 52.3% of women had the presence of an obstetric nurse during labor, only 0.7% received delivery assistance from this professional. Among women with labor onset, 58.3% had a vaginal delivery, and only 3.2% were assisted exclusively by obstetric nurses during labor and delivery. Overall, 76.6% of participants underwent cesarean section. CONCLUSION: Obstetric nurses were frequently present during labor but rarely performed delivery care in private hospitals. Their limited participation suggests underutilization of this professional group within the studied setting.